117- Manual method is relatively easy to be performed and less time
consuming than the semi-automated method. On the other
hand, the semi-automated method has the advantages of han-
dling smaller tissues and needs less expertise. - The best outcomes in practice to get a good depth for tissue
insertion are by expert hands. Some users can find it conve-
nient to use a permanent marker to draw a mark on the needle
indicating a fixed sampling depth.
References
- Simon R, Mirlacher M, Sauter G (2005) Tissue
microarrays. Methods Mol Med 114:257–268 - Langer R, Von Rahden BH, Nahrig J, Von
Weyhern C, Reiter R, Feith M, Stein HJ,
Siewert JR, Höfler H, Sarbia M (2006)
Prognostic significance of expression patterns
of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin
D1 and epidermal growth factor receptor in
esophageal adenocarcinoma: a tissue microar-
ray study. J Clin Pathol 59:631–634 - Kuester D, Dar AA, Moskaluk CC, Krueger
S, Meyer F, Hartig R, Stolte M, Malfertheiner
P, Lippert H, Roessner A, El-Rifai W,
Schneider-Stock R (2007) Early involvement
of death-associated protein kinase promoter
hypermethylation in the carcinogenesis of
Barrett’s esophageal adenocarcinoma and its
association with clinical progression. Neoplasia
9:236–245 - Boult J, Roberts K, Brookes MJ, Hughes S,
Bury JP, Cross SS, Anderson GJ, Spychal R,
Iqbal T, Tselepis C (2008) Overexpression of
cellular iron import proteins is associated with
malignant progression of esophageal adenocar-
cinoma. Clin Cancer Res 14:379–387 - Thompson SK, Sullivan TR, Davies R,
Ruszkiewicz AR (2011) Her-2/neu gene
amplification in esophageal adenocarcinoma
and its influence on survival. Ann Surg Oncol
18:2010–2017 - Peters JH, Zhou Z (2011) HER2 amplification,
overexpression and score criteria in esophageal
adenocarcinoma. Mod Pathol 24:899–907 - Storr SJ, Pu X, Davis J, Lobo D, Reece-Smith
AM, Parsons SL, Madhusudan S, Martin SG
(2013) Expression of the calpain system is asso-
ciated with poor clinical outcome in gastro-
esophageal adenocarcinomas. J Gastroenterol
48:1213–1221 - Prins MJ, Ruurda JP, Lolkema MP, Sitarz R,
Ten Kate FJ, van Hillegersberg R (2015) The
role of biological markers of epithelial to mes-
enchymal transition in esophageal adenocarci-
noma, an immunohistochemical study. J Clin
Pathol 68:529–535
9. Stein AV, Dislich B, Blank A, Guldener L, Kröll
D, Seiler CA, Langer R (2017) High intratu-
moural but not peritumoural inflammatory
host response is associated with better progno-
sis in primary resected esophageal adenocarci-
nomas. Pathology 49:30–37
10. Prins MJ, Verhage RJ, Ruurda JP, ten Kate FJ,
van Hillegersberg R (2013) Over-expression of
phosphorylated mammalian target of rapamy-
cin is associated with poor survival in esopha-
geal adenocarcinoma: a tissue microarray study.
J Clin Pathol 66:224–228
11. Dibb M, Han N, Choudhury J, Hayes S,
Valentine H, West C, Ang YS, Sharrocks AD
(2016) The FOXM1-PLK1 axis is commonly
upregulated in esophageal adenocarcinoma. Br
J Cancer 107:1766–1775
12. Geppert CI, Rümmele P, Sarbia M, Langer
R, Feith M, Morrison L, Pestova E,
Schneider-Stock R, Hartmann A, Rau TT
(2014) Multi-colour FISH in esophageal
adenocarcinoma-predictors of prognosis
independent of stage and grade. Br J Cancer
110:2985–2995
13. Kononen J, Bubendorf L, Kallioniemi A,
Bärlund M, Schraml P, Leighton S, Torhorst
J, Mihatsch MJ, Sauter G, Kallioniemi OP
(1998) Tissue microarrays for high-through-
put molecular profiling of tumor specimens.
Nat Med 4:844–847
14. Garcia JF, Camacho FI, Morente M, Fraga
M, Montalbán C, Alvaro T, Bellas C, Castaño
A, Díez A, Flores T, Martin C, Martinez
MA, Mazorra F, Menárguez J, Mestre MJ,
Mollejo M, Sáez AI, Sánchez L, Piris MA,
Spanish Hodgkin Lymphoma Study Group
(2002) Hodgkin’s and Reed-Sternberg cells
harbor alterations in the major tumor sup-
pressor pathways and cell-cycle checkpoints:
analyses using tissue-microarrays. Blood
12:681–689
15. Merseburger AS, Kuczyk MA, Serth J,
Bokemeyer C, Young DY, Sun L, Connelly
RR, McLeod DG, Mostofi FK, Srivastava SK,
Stenzl A, Moul JW, Sesterhenn IA (2003)
TMA and Esophageal Adenocarcinoma